USPTO Examiner GRAY PHILLIP A - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19238841Internal Laryngeal Muscle Injection ToolJune 2025October 2025Allow401NoNo
19199999INTRAORAL GASTROINTESTINAL ACCESS DEVICE AND RELATED METHODSMay 2025January 2026Allow811YesNo
19017212TRANSDERMAL DRUG DELIVERY WITH A FORCE-CALIBRATED MAGNETIC MICRONEEDLE PATCHJanuary 2025March 2025Allow200NoNo
18976281TREATMENT OF INFLAMMATORY DISORDERSDecember 2024January 2026Allow1310YesNo
18969639AREA ARRAY MICRO-NEEDLE STRUCTUREDecember 2024February 2025Allow200NoNo
18871397CLASSIFYING OF A POSITION OF A CATHETER IN RELATION TO A DIAPHRAGMDecember 2024April 2025Allow400NoNo
18863666Colchicine Hydrogel Microneedle and Preparation Method ThereofNovember 2024March 2025Allow500NoNo
18818896DRUG DELIVERY PART FOR VISUAL EAR PICKING STICKAugust 2024January 2025Allow400NoNo
18757648MICRO-CHANNELING SYSTEMJune 2024September 2025Abandon1420NoNo
18749277PERSONALIZED EVENT DETECTIONJune 2024February 2025Allow800NoNo
18734798SYSTEM AND METHOD FOR CONFIGURING A RULE SET FOR MEDICAL EVENT MANAGEMENT AND RESPONSESJune 2024February 2025Allow900NoNo
18667224DUAL HORMONE DELIVERY SYSTEM FOR REDUCING IMPENDING HYPOGLYCEMIA AND/OR HYPERGLYCEMIA RISKMay 2024August 2025Allow1510NoNo
18658880SYSTEMS AND METHODS FOR SECURING CATHETERSMay 2024January 2025Allow800NoNo
18642514SOFT PUSH TABS FOR CATHETER ADAPTERApril 2024January 2025Allow900NoNo
18639352CARTRIDGE AND APPLICATOR FOR DRUG DELIVERY AND MICRONEEDLE PATCH USED THEREFORApril 2024May 2025Allow1310NoNo
18623191Stabilization Devices for Vascular Access and Methods of Using the SameApril 2024November 2024Allow800NoNo
18617065PATIENT SIMULATORMarch 2024February 2025Allow1120NoNo
18692107PERITONEAL DIALYSIS CYCLER HAVING DUAL PERISTALTIC PUMPSMarch 2024June 2024Allow400NoNo
18585706Cartridge Insertion Mechanism for a Fluid Delivery DeviceFebruary 2024July 2025Allow1720NoNo
18443798DEVICES, METHODS AND COMPOSITIONS FOR REPRODUCTIVE ORGANSFebruary 2024December 2024Allow1010NoNo
18436203SAFETY CATHETER WITH PASSIVE RELEASEFebruary 2024December 2024Allow1110NoNo
18292749Devices, Methods and Compositions for Reproductive OrgansJanuary 2024July 2025Allow1820NoNo
18397486Medical Line Holder DeviceDecember 2023May 2024Allow510NoNo
18525612Active Agent Delivery Devices and Methods of Using the sameNovember 2023October 2025Abandon2320YesNo
18525738OCULAR DELIVERY SYSTEMS AND METHODSNovember 2023September 2024Allow1000NoNo
18514406HOME RENAL THERAPY SYSTEM AND MACHINENovember 2023August 2024Allow900NoNo
18494194VASCULAR ACCESS WIRE TIP COMPRISING A CRANKOctober 2023January 2024Allow300NoNo
18492144SYRINGE AND KIT FOR ADMINISTERING PREDETERMINED SPECIFIC EPINEPHRINE DOSESOctober 2023December 2025Allow2511NoNo
18486218CATHETER ASSEMBLYOctober 2023October 2024Allow1200NoNo
18378202PUMP DEVICE HAVING A DETECTION DEVICEOctober 2023August 2024Allow1000NoNo
18479982CATHETER ASSEMBLYOctober 2023November 2024Allow1310NoNo
18370453ENDOVASCULAR DEVICES AND METHODSSeptember 2023October 2024Allow1300NoNo
18237328CLOSED IV ACCESS DEVICE WITH PADDLE GRIP NEEDLE HUB AND FLASH CHAMBERAugust 2023July 2025Allow2320NoNo
18450159MULTIPLE-PULL-WIRE ROBOTIC INSTRUMENT ARTICULATIONAugust 2023August 2025Allow2510NoNo
18263486DISPOSABLE NEEDLE-HOLDING CARTRIDGE FOR A DEVICE FOR COSMETIC TREATMENTSJuly 2023February 2026Allow3100NoNo
18225442Vascular Access Device Assembly Facilitating Single-Handed Patency Probe AdvancementJuly 2023July 2024Allow1100NoNo
18216342SYSTEM AND METHOD FOR BUTTERFLY NEEDLE ASSEMBLYJune 2023February 2026Allow3200NoNo
18343305INFUSION DEVICES AND RELATED METHODS AND SYSTEMS FOR PREEMPTIVE ALERTINGJune 2023December 2024Allow1800NoNo
18205580INTRANASAL ADMINISTRATIONJune 2023June 2024Allow1200NoNo
18203091Quick release connection for patient tube assemblyMay 2023July 2024Allow1410NoNo
18302755MEDICAL SYSTEMS AND METHODSApril 2023March 2024Allow1100NoNo
18300839SYSTEM AND METHOD FOR CONFIGURING A RULE SET FOR MEDICAL EVENT MANAGEMENT AND RESPONSESApril 2023March 2024Allow1100NoNo
18127599CARTRIDGE AND APPLICATOR FOR DRUG DELIVERY AND MICRONEEDLE PATCH USED THEREFORMarch 2023February 2024Allow1000NoNo
18044657DEVICES AND PROCESSES FOR DELIVERY OF THERAPEUTIC FLUIDSMarch 2023November 2025Allow3200NoNo
18024585COATED MICRONEEDLE WITH MULTILAYER STRUCTURE, METHOD FOR PREPARING THE SAME AND MICRONEEDLE PATCH COMPRISING COATED MICRONEEDLEMarch 2023February 2026Allow3610NoNo
18116757STYLET WITH IMPROVED THREADABILITYMarch 2023October 2023Allow711NoNo
18116708CATHETER WITH AN ASYMMETRIC TIPMarch 2023February 2024Allow1100NoNo
18107249CATHETER ASSEMBLY SUPPORT DEVICE, SYSTEMS, AND METHODSFebruary 2023July 2024Allow1710NoNo
18096149SAFETY CATHETER WITH PASSIVE RELEASEJanuary 2023December 2023Allow1200NoNo
18092419METHOD OF USING MEDICINAL FLUID INJECTION DEVICEJanuary 2023July 2024Allow1910NoNo
18090107Dermal Patch for Delivering a PharmaceuticalDecember 2022August 2024Allow2021NoNo
18090026Dermal Patch for Collecting a Physiological SampleDecember 2022February 2024Allow1411NoNo
18090063Dermal Patch with a Diagnostic Test StripDecember 2022September 2024Allow2121NoNo
18146464MICRONEEDLE ARRAY UNITDecember 2022March 2026Abandon3810NoNo
18081936MICRONEEDLE ARRAY-BASED ELECTRODE COMPRISING ORGANIC PHOTOVOLTAIC SUBSTANCES AND ARTIFICIAL RETINA DEVICE COMPRISING THE SAMEDecember 2022September 2025Allow3300NoNo
18078070Guide Catheter and Method of UseDecember 2022April 2024Allow1600NoNo
18007654MICRONEEDLE APPLICATORDecember 2022October 2025Allow3500NoNo
17994146MULTI-PURPOSE AUTOMATIC INJECTORNovember 2022March 2023Allow400NoNo
17927445HEAT-RESISTANT IMPLANTABLE POLYMER MICRONEEDLE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOFNovember 2022March 2026Allow4010NoNo
17983886Vascular Access Instrument Having a Fluid Permeable Structure, and Related Devices and MethodsNovember 2022June 2025Allow3100NoNo
17954889EXPANDABLE INTRODUCER SHEATH FOR MEDICAL DEVICESeptember 2022October 2025Allow3710NoNo
17953243PULLWIRE CROWN AND CROWN SLEEVE FOR CATHETER ASSEMBLYSeptember 2022April 2024Allow1910NoNo
17953202Apparatus and Method for the Preparation and Administration of Blood ComponentsSeptember 2022September 2025Allow3600NoNo
17947785PUMP DEVICE HAVING A DETECTION DEVICESeptember 2022July 2023Allow1000NoNo
17912593TREATMENT OF INTERNAL SPACES USING PLASMA GENERATING DEVICESeptember 2022October 2025Allow3700NoNo
17947340MEDICAL SYSTEM INCLUDING STEERABLE CATHETERSeptember 2022August 2025Allow3500NoNo
17911863INJECTION DEVICES WITH AUTOMATIC PRIMINGSeptember 2022August 2025Allow3500NoNo
17911132GELATIN METHACRYLOYL-BASED MICRONEEDLE PATCHES FOR DELIVERY OF WATER-INSOLUBLE DRUGSSeptember 2022September 2025Allow3600NoNo
17898670Keyed Interlocking Airway Assist DeviceAugust 2022February 2024Allow1820NoNo
17898290PORT-FLUSHING CONTROL VALVEAugust 2022October 2023Allow1300NoNo
17800736Microneedle Array, Molding for Manufacturing a Microneedle Array, and Method for Manufacturing a Microneedle ArrayAugust 2022March 2026Allow4220NoNo
17820314SURGICAL SYSTEMS INCLUDING A POWER LOSS MITIGATION SUBSYSTEMAugust 2022May 2025Allow3300NoNo
17820139ORTHOGONALLY ORIENTED STEERING CONTROLS FOR ICE CATHETERAugust 2022October 2025Allow3800NoNo
17888376Stabilizing Device Having a Snap ClampAugust 2022August 2024Allow2420NoNo
17876188CATHETER SHAFT AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSJuly 2022June 2024Abandon2310YesNo
17814557ELECTROSTIMULATION BASED DRUG DELIVERY SYSTEM AND METHOD FOR USING THEREOFJuly 2022November 2025Allow3900NoNo
17870637CATHETER ASSEMBLY HAVING A SIDE PORT VALVEJuly 2022May 2024Allow2220NoNo
17811420INTERVERTEBRAL DISC PUNCTURE AND TREATMENT SYSTEMJuly 2022July 2024Allow2420NoYes
17791452GELATIN-BASED MICRONEEDLE PATCH FOR MINIMALLY-INVASIVE EXTRACTION OF BODILY FLUIDSJuly 2022October 2025Allow3910YesNo
17844990BIDIRECTIONAL FLOW CATHETERJune 2022December 2023Abandon1810NoNo
17782201MICRONEEDLE ARRAY, ACTUATOR AND METHOD OF USEJune 2022February 2026Allow4510NoNo
17779903TRANSDERMAL COLD ATMOSPHERIC PLASMA-MEDIATED IMMUNE CHECKPOINT BLOCKADE THERAPYMay 2022November 2025Abandon4210NoNo
17751695RECOMBINANT SUBUNIT VACCINE MICRONEEDLE PRODUCT AS WELL AS PREPARATION METHOD AND APPLICATION THEREOFMay 2022December 2025Abandon4310NoNo
17750309INACTIVATED VIRUS VACCINE MICRONEEDLE PRODUCT AS WELL AS PREPARATION METHOD AND APPLICATION THEREOFMay 2022December 2025Abandon4310NoNo
17747393DEFLECTABLE CATHETER WITH A FLEXIBLY ATTACHED TIP SECTIONMay 2022June 2023Allow1300NoNo
17747287MICRONEEDLE SYSTEM FOR ADMINISTERING LIQUID FORMULATIONSMay 2022December 2025Abandon4310NoNo
17768443INTRAVASCULAR CATHETER DEVICEApril 2022January 2024Allow2100NoNo
17718567CATHETER ASSEMBLY HAVING AN INJECTION PORT AND RELATED METHODSApril 2022October 2023Allow1810NoNo
17718630Method and Apparatus for Assisting, Checking, and Confirming Nasogastric and Orogastric Tube Insertion and PlacementApril 2022May 2024Allow2530YesYes
17715630CATHETER MANAGEMENT DEVICEApril 2022October 2024Allow3140YesNo
17695914Hand-held microneedling device for local puncturing of a skin, skin puncturing device, and itemMarch 2022September 2025Allow4210NoNo
17653960PROCESS FOR HAIR GROWTHMarch 2022September 2025Abandon4310NoNo
17685297OCCLUSION DETECTION IN AMBULATORY MEDICAMENT PUMPSMarch 2022April 2023Abandon1311NoNo
17652816Personalized event detectionFebruary 2022March 2024Allow2510YesNo
17682659HOME RENAL THERAPY SYSTEM AND MACHINEFebruary 2022June 2023Allow1600NoNo
17671296SYSTEM AND METHOD FOR SELECTIVE PRESSURE-CONTROLLED THERAPEUTIC DELIVERYFebruary 2022March 2025Allow3720NoNo
17633474APPLICATOR FOR DRUG DELIVERY AND MICRONEEDLE PATCH USED THEREFORFebruary 2022April 2024Allow2600NoNo
17633347TREATMENT MEDIA DELIVERY DEVICE AND METHODS FOR TARGETED DELIVERY THEREOFFebruary 2022December 2025Abandon4610NoNo
17579222Self-Retracting Mechanized Syringe and Methods of UseJanuary 2022November 2022Allow1020YesNo
17571141CATHETER ASSEMBLYJanuary 2022July 2023Allow1800NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner GRAY, PHILLIP A.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
4
Examiner Affirmed
1
(25.0%)
Examiner Reversed
3
(75.0%)
Reversal Percentile
90.0%
Higher than average

What This Means

With a 75.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
43
Allowed After Appeal Filing
16
(37.2%)
Not Allowed After Appeal Filing
27
(62.8%)
Filing Benefit Percentile
61.1%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 37.2% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner GRAY, PHILLIP A - Prosecution Strategy Guide

Executive Summary

Examiner GRAY, PHILLIP A works in Art Unit 3783 and has examined 392 patent applications in our dataset. With an allowance rate of 86.7%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 35 months.

Allowance Patterns

Examiner GRAY, PHILLIP A's allowance rate of 86.7% places them in the 65% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by GRAY, PHILLIP A receive 1.88 office actions before reaching final disposition. This places the examiner in the 45% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by GRAY, PHILLIP A is 35 months. This places the examiner in the 41% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +7.0% benefit to allowance rate for applications examined by GRAY, PHILLIP A. This interview benefit is in the 35% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 35.1% of applications are subsequently allowed. This success rate is in the 79% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 18.6% of cases where such amendments are filed. This entry rate is in the 22% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 133.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 87% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 87.9% of appeals filed. This is in the 81% percentile among all examiners. Of these withdrawals, 58.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 44.0% are granted (fully or in part). This grant rate is in the 37% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.5% of allowed cases (in the 60% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.